A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to test the hypothesis that an intervention of lifestyle modification will positively impact women with breast cancer who are overweight and/or obese. To that end, our primary endpoint is to examine the effects of a practical lifestyle intervention that can be implemented by overweight or obese women (BMI greater or equal to 25) with early stage breast cancer (I-III) on outcomes such as body weight and change in BMI over the course of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2013
CompletedStudy Start
First participant enrolled
September 1, 2013
CompletedFirst Posted
Study publicly available on registry
January 16, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedJuly 21, 2016
July 1, 2016
2.7 years
July 16, 2013
July 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lifestyle intervention
To examine the effects of a practical lifestyle intervention that can be implemented by overweight or obese women (BMI greater or equal to 25) with early stage breast cancer (I-III) on outcomes such as body weight and change in BMI over the course of the study.
One year
Secondary Outcomes (1)
Lipid Profiles, hemoglobin A1C
1 year
Study Arms (1)
Diet and Exercise
EXPERIMENTALProspective, observational, cohort study, with a proposed start date of May 2013 and proposed end date of June 2018. Our goal is to gather data on a total of 200 patients: 100 patients (study group) will be prospectively enrolled, while data on another 100 patients (control) will be accessed through retrospective data collection. Number of patients to be analyzed will depend on enrollment and patient compliance. We would like to enroll the proposed 100 patients in the first 1-3 years of the study (approximately 30 per year).
Interventions
Upon enrollment, the patient will be asked to meet with a dietitian to assess the individual patient's current diet and exercise routines. In the first session, the dietitian will provide individual counseling and together with the patient devise weight loss / exercise strategies that fit the patients' lifestyle. Following the initial assessment, patients will embark on a weekly program, with weekly meetings lasting 30min - 1h. Patients will be asked to record meal portions weekly in a Food Log (Appendix B), according to the established goal. At each meeting, the dietitian will review the Food Log with the patient and evaluate progress.
Eligibility Criteria
You may qualify if:
- DCIS
- Women with stage 0 - III breast cancer (histologic type ductal or lobular)
- BMI \>=25
- Patients must have completed all chemotherapy
- Patients may be on hormonal therapy or radiation therapy
- Age \>= 18 years old to 89 Years old
- Patient must be medically stable and without significant impairments that would preclude following the proposed intervention regimen.
- Time of diagnosis: patients enrolled are within 1 month to 18 months post-diagnosis.
You may not qualify if:
- Metastatic breast cancer patients and patients with inoperable or active loco-regional disease.
- Patients following alternative/complementary diets or taking high dose antioxidant supplements.
- Patients with a physical/psychiatric impairment that would seriously impair their physical mobility.
- Patients who are currently suffering from severe nausea, anorexia or other diseases affecting health (e.g. arthritis and multiple sclerosis).
- Patients younger than 18 and older than 89 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South Miami Hospital
Miami, Florida, 33143, United States
Related Publications (3)
Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76. doi: 10.1093/jnci/djg060.
PMID: 14519753BACKGROUNDChristy SM, Mosher CE, Sloane R, Snyder DC, Lobach DF, Demark-Wahnefried W. Long-term dietary outcomes of the FRESH START intervention for breast and prostate cancer survivors. J Am Diet Assoc. 2011 Dec;111(12):1844-51. doi: 10.1016/j.jada.2011.09.013.
PMID: 22117660BACKGROUNDDemark-Wahnefried W, Morey MC, Sloane R, Snyder DC, Miller PE, Hartman TJ, Cohen HJ. Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors. J Clin Oncol. 2012 Jul 1;30(19):2354-61. doi: 10.1200/JCO.2011.40.0895. Epub 2012 May 21.
PMID: 22614994BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Amelia Rodrigues, MD
BHSF
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Research Administrator
Study Record Dates
First Submitted
July 16, 2013
First Posted
January 16, 2014
Study Start
September 1, 2013
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
July 21, 2016
Record last verified: 2016-07